School of Pharmacy
Menu
Search
Search
Overview
About Us
Accreditation
Administration
Advisory Boards
Departments
Medicinal Chemistry
Pharmaceutics
Pharmacotherapy & Outcomes Science
Admissions
Pharm.D.
Graduate
Postgraduate
Combined Degree
Get Involved
Continuing Education
VCU Make it real Campaign
Scholarships
Research
Centers & Programs
Community Outreach
Experiential Education
Contact Us
Directory
myVCU
Email (Faculty)
Email (Student)
Blackboard
Resources
Events
Search
Directory
Last Name Search
Department Search
Faculty Type Search
Back
Rollin "Ron" L. Ballentine
, Pharm.D., CSCS
Emeritus Professor
Department of Pharmacotherapy & Outcomes Science
Smith Building, Room 500c
School of Pharmacy
Dept of Pharmacotherapy & Outcomes Science
410 N 12
th
Street
P.O. Box 980533
Richmond, VA 23298-0533
(804) 828-3004
(804) 827-0002
rlballen@vcu.edu
Bio
Publications
../bin/
Area of Focus
Primary Care
Smoking Cessation
Education
Pharm.D., Clinical Pharmacy (University of Michigan, 1973)
B.S., Pharmacy (University of Cincinnati, 1971)
Pharm.D., (University of Michigan, 1973)
Post-Graduate Training
Pharmacy Residency - Hospital Pharmacy (University of Michigan, 1974)
Professional Experience
(1987 - Present) Associate Professor of Pharmacy, MCV/VCU School of Pharmacy
(1985 - 1987) Adjunct Associate Professor of Clinical Pharmacy, University of Houston
(1981 - 1985) Associate Professor of Clinical Pharmacy (with tenure), University of Houston
(1974 - 1981) Assistant Professor of Clinical Pharmacy, University of Houston
Publications
Recent Publications
1. Faw C, Ballentine R, Ballentine L, VanEys J. Unproved cancer remedies: A Survey of use in pediatric outpatients. Journal of the American Medical Association. 1977; 238:1536-1538. 2. Frick GA, Ballentine R, Driever CW, Kramer WG. Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum (II) administered with hydration and mannitol diuresis. Cancer Treatment Reports. 1979; 63:13-16. 3. Dozier N, Ballentine R, Adams S, Okafor K. Acquired Immune Deficiency Syndrome and the management of associated opportunistic infections. Drug Intelligence and Clinical Pharmacy. 1983; 17:798-807. 4. Chang SL, Kramer WG, Feldman S, Ballentine R, Frankel LS. Bioavailability of allopurinol oral and rectal dosage forms. American Journal of Hospital Pharmacy. 1981; 38:365-368. 5. Ballentine R, Primeaux J. Information on antineoplastic drugs for non-oncologist physicians. American Journal of Hospital Pharmacy 1977; 34:839-843.